Search results
GSK's Key Drugs to Drive Sales in a Sluggish Second Half
Zacks via Yahoo Finance· 2 years agoGSK's specialty products like Dovato, Nucala, Trelegy Ellipta, Shingrix are driving sales, making up...
GSK's New Drugs and Pipeline Hold the Key to Growth in 2023
Zacks via Yahoo Finance· 1 year agoGSK's specialty products like Dovato, Nucala, Trelegy Ellipta and Shingrix are likely to drive...
GSK Gears Up to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoGSK plc. GSK will report fourth-quarter 2022 results on Feb 1, before the opening bell. In the last...
GSK's Q3 Earnings Beat, Ups 2022 Sales Outlook, Stock Up
Zacks via Yahoo Finance· 1 year agoGSK plc GSK reported third-quarter 2022 adjusted earnings of $1.09 per American depositary share...
GSK strikes £1.1bn deal for asthma drugmaker
The Telegraph via Yahoo Finance· 4 months agoIt is hoped the treatment that's been purchased by GSK will help patients cut down on the use of inhalers - bymuratdeniz GSK has bought a drug to treat...
Why Is Glaxo (GSK) Up 6.7% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for GSK (GSK). Shares have added about 6.7% in...
Zacks Industry Outlook Highlights Gilead Sciences, GSK, Immunocore and Syndax Pharmaceuticals
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – December 28, 2022 – Today, Zacks Equity Research discusses...
4 Large Drug Stocks to Watch as the Industry Recovers
Zacks via Yahoo Finance· 2 years agoDrug/biotech companies are likely to see significant advances in innovation in 2022. In the...
GSK bets $2 billion on Bellus cough drug to soothe pipeline fears
Reuters via Yahoo News· 1 year ago(Reuters) -GSK plans to buy Canada-based drug developer Bellus Health Inc in an all-cash deal for $2...
GSK to buy asthma drug startup Aiolos for $1B
BioPharma Dive via Yahoo Finance· 4 months agoOver the span of five months, biotechnology startup Aiolos Bio launched, raised initial funding from venture investors and negotiated a $1 billion buyout...
